J&J Earnings Beat, Revenue Misses In Q1
2022.04.19 13:36
J&J Earnings Beat, Revenue Misses In Q1
Investing.com – J&J reported on Tuesday first quarter earnings that beat analysts’ forecasts and revenue that fell short of expectations.
J&J announced earnings per share of $2.67 on revenue of $23.43B. Analysts polled by Investing.com anticipated EPS of $2.59 on revenue of $23.69B.
J&J shares are up 3% from the beginning of the year, still down 3.55% from its 52 week high of $184.20 set on April 11. They are outperforming the S&P 500 which is down 7.86% from the start of the year.
J&J follows other major Healthcare sector earnings this month
J&J’s report follows an earnings beat by UnitedHealth on Thursday, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.38 on revenue of $78,786M.
BioNTech had beat expectations on March 30 with first quarter EPS of $12.18 on revenue of $5.53B, compared to forecast for EPS of $7.44 on revenue of $3.92B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
